Global Tardive Dyskinesia Treatment Market Research Report 2024

Report ID: 1981243 | Published Date: Dec 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tardive Dyskinesia Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Medical Treatement
        1.2.3 Self Care
    1.3 Market by Application
        1.3.1 Global Tardive Dyskinesia Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Tardive Dyskinesia Treatment Market Perspective (2017-2028)
    2.2 Tardive Dyskinesia Treatment Growth Trends by Region
        2.2.1 Tardive Dyskinesia Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Tardive Dyskinesia Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Tardive Dyskinesia Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Tardive Dyskinesia Treatment Market Dynamics
        2.3.1 Tardive Dyskinesia Treatment Industry Trends
        2.3.2 Tardive Dyskinesia Treatment Market Drivers
        2.3.3 Tardive Dyskinesia Treatment Market Challenges
        2.3.4 Tardive Dyskinesia Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Tardive Dyskinesia Treatment Players by Revenue
        3.1.1 Global Top Tardive Dyskinesia Treatment Players by Revenue (2017-2022)
        3.1.2 Global Tardive Dyskinesia Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Tardive Dyskinesia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Tardive Dyskinesia Treatment Revenue
    3.4 Global Tardive Dyskinesia Treatment Market Concentration Ratio
        3.4.1 Global Tardive Dyskinesia Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Treatment Revenue in 2021
    3.5 Tardive Dyskinesia Treatment Key Players Head office and Area Served
    3.6 Key Players Tardive Dyskinesia Treatment Product Solution and Service
    3.7 Date of Enter into Tardive Dyskinesia Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia Treatment Breakdown Data by Type
    4.1 Global Tardive Dyskinesia Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Tardive Dyskinesia Treatment Forecasted Market Size by Type (2023-2028)
5 Tardive Dyskinesia Treatment Breakdown Data by Application
    5.1 Global Tardive Dyskinesia Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Tardive Dyskinesia Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Tardive Dyskinesia Treatment Market Size (2017-2028)
    6.2 North America Tardive Dyskinesia Treatment Market Size by Country (2017-2022)
    6.3 North America Tardive Dyskinesia Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Tardive Dyskinesia Treatment Market Size (2017-2028)
    7.2 Europe Tardive Dyskinesia Treatment Market Size by Country (2017-2022)
    7.3 Europe Tardive Dyskinesia Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Tardive Dyskinesia Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Tardive Dyskinesia Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Tardive Dyskinesia Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Tardive Dyskinesia Treatment Market Size (2017-2028)
    9.2 Latin America Tardive Dyskinesia Treatment Market Size by Country (2017-2022)
    9.3 Latin America Tardive Dyskinesia Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Tardive Dyskinesia Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Tardive Dyskinesia Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Tardive Dyskinesia Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Teva Pharmaceutical Industries Ltd
        11.1.1 Teva Pharmaceutical Industries Ltd Company Detail
        11.1.2 Teva Pharmaceutical Industries Ltd Business Overview
        11.1.3 Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Introduction
        11.1.4 Teva Pharmaceutical Industries Ltd Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.1.5 Teva Pharmaceutical Industries Ltd Recent Development
    11.2 Neurocrine Biosciences, Inc
        11.2.1 Neurocrine Biosciences, Inc Company Detail
        11.2.2 Neurocrine Biosciences, Inc Business Overview
        11.2.3 Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Introduction
        11.2.4 Neurocrine Biosciences, Inc Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.2.5 Neurocrine Biosciences, Inc Recent Development
    11.3 Sun Pharmaceutical Industries Ltd
        11.3.1 Sun Pharmaceutical Industries Ltd Company Detail
        11.3.2 Sun Pharmaceutical Industries Ltd Business Overview
        11.3.3 Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Introduction
        11.3.4 Sun Pharmaceutical Industries Ltd Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.3.5 Sun Pharmaceutical Industries Ltd Recent Development
    11.4 SteriMax Inc.
        11.4.1 SteriMax Inc. Company Detail
        11.4.2 SteriMax Inc. Business Overview
        11.4.3 SteriMax Inc. Tardive Dyskinesia Treatment Introduction
        11.4.4 SteriMax Inc. Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.4.5 SteriMax Inc. Recent Development
    11.5 Adamas Pharmaceuticals, Inc
        11.5.1 Adamas Pharmaceuticals, Inc Company Detail
        11.5.2 Adamas Pharmaceuticals, Inc Business Overview
        11.5.3 Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Introduction
        11.5.4 Adamas Pharmaceuticals, Inc Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.5.5 Adamas Pharmaceuticals, Inc Recent Development
    11.6 Sanis
        11.6.1 Sanis Company Detail
        11.6.2 Sanis Business Overview
        11.6.3 Sanis Tardive Dyskinesia Treatment Introduction
        11.6.4 Sanis Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.6.5 Sanis Recent Development
    11.7 AbbVie Inc.
        11.7.1 AbbVie Inc. Company Detail
        11.7.2 AbbVie Inc. Business Overview
        11.7.3 AbbVie Inc. Tardive Dyskinesia Treatment Introduction
        11.7.4 AbbVie Inc. Revenue in Tardive Dyskinesia Treatment Business (2017-2022)
        11.7.5 AbbVie Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Tardive Dyskinesia Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Medical Treatement
    Table 3. Key Players of Self Care
    Table 4. Global Tardive Dyskinesia Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Tardive Dyskinesia Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Tardive Dyskinesia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Tardive Dyskinesia Treatment Market Share by Region (2017-2022)
    Table 8. Global Tardive Dyskinesia Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Tardive Dyskinesia Treatment Market Share by Region (2023-2028)
    Table 10. Tardive Dyskinesia Treatment Market Trends
    Table 11. Tardive Dyskinesia Treatment Market Drivers
    Table 12. Tardive Dyskinesia Treatment Market Challenges
    Table 13. Tardive Dyskinesia Treatment Market Restraints
    Table 14. Global Tardive Dyskinesia Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Tardive Dyskinesia Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Tardive Dyskinesia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia Treatment as of 2021)
    Table 17. Ranking of Global Top Tardive Dyskinesia Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Tardive Dyskinesia Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Tardive Dyskinesia Treatment Product Solution and Service
    Table 21. Date of Enter into Tardive Dyskinesia Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Tardive Dyskinesia Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Tardive Dyskinesia Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Tardive Dyskinesia Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Tardive Dyskinesia Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Tardive Dyskinesia Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Tardive Dyskinesia Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Tardive Dyskinesia Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Tardive Dyskinesia Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Tardive Dyskinesia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Tardive Dyskinesia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Tardive Dyskinesia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Tardive Dyskinesia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Tardive Dyskinesia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Tardive Dyskinesia Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Tardive Dyskinesia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Tardive Dyskinesia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Tardive Dyskinesia Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Tardive Dyskinesia Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Teva Pharmaceutical Industries Ltd Company Detail
    Table 42. Teva Pharmaceutical Industries Ltd Business Overview
    Table 43. Teva Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Product
    Table 44. Teva Pharmaceutical Industries Ltd Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 45. Teva Pharmaceutical Industries Ltd Recent Development
    Table 46. Neurocrine Biosciences, Inc Company Detail
    Table 47. Neurocrine Biosciences, Inc Business Overview
    Table 48. Neurocrine Biosciences, Inc Tardive Dyskinesia Treatment Product
    Table 49. Neurocrine Biosciences, Inc Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 50. Neurocrine Biosciences, Inc Recent Development
    Table 51. Sun Pharmaceutical Industries Ltd Company Detail
    Table 52. Sun Pharmaceutical Industries Ltd Business Overview
    Table 53. Sun Pharmaceutical Industries Ltd Tardive Dyskinesia Treatment Product
    Table 54. Sun Pharmaceutical Industries Ltd Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 55. Sun Pharmaceutical Industries Ltd Recent Development
    Table 56. SteriMax Inc. Company Detail
    Table 57. SteriMax Inc. Business Overview
    Table 58. SteriMax Inc. Tardive Dyskinesia Treatment Product
    Table 59. SteriMax Inc. Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 60. SteriMax Inc. Recent Development
    Table 61. Adamas Pharmaceuticals, Inc Company Detail
    Table 62. Adamas Pharmaceuticals, Inc Business Overview
    Table 63. Adamas Pharmaceuticals, Inc Tardive Dyskinesia Treatment Product
    Table 64. Adamas Pharmaceuticals, Inc Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 65. Adamas Pharmaceuticals, Inc Recent Development
    Table 66. Sanis Company Detail
    Table 67. Sanis Business Overview
    Table 68. Sanis Tardive Dyskinesia Treatment Product
    Table 69. Sanis Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 70. Sanis Recent Development
    Table 71. AbbVie Inc. Company Detail
    Table 72. AbbVie Inc. Business Overview
    Table 73. AbbVie Inc. Tardive Dyskinesia Treatment Product
    Table 74. AbbVie Inc. Revenue in Tardive Dyskinesia Treatment Business (2017-2022) & (US$ Million)
    Table 75. AbbVie Inc. Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tardive Dyskinesia Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Medical Treatement Features
    Figure 3. Self Care Features
    Figure 4. Global Tardive Dyskinesia Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Tardive Dyskinesia Treatment Report Years Considered
    Figure 9. Global Tardive Dyskinesia Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Tardive Dyskinesia Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Tardive Dyskinesia Treatment Market Share by Region: 2021 VS 2028
    Figure 12. Global Tardive Dyskinesia Treatment Market Share by Players in 2021
    Figure 13. Global Top Tardive Dyskinesia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia Treatment as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Tardive Dyskinesia Treatment Revenue in 2021
    Figure 15. North America Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Tardive Dyskinesia Treatment Market Share by Country (2017-2028)
    Figure 17. United States Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Tardive Dyskinesia Treatment Market Share by Country (2017-2028)
    Figure 21. Germany Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Tardive Dyskinesia Treatment Market Share by Region (2017-2028)
    Figure 29. China Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Tardive Dyskinesia Treatment Market Share by Country (2017-2028)
    Figure 37. Mexico Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Tardive Dyskinesia Treatment Market Share by Country (2017-2028)
    Figure 41. Turkey Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Tardive Dyskinesia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 44. Neurocrine Biosciences, Inc Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 45. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 46. SteriMax Inc. Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 47. Adamas Pharmaceuticals, Inc Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 48. Sanis Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 49. AbbVie Inc. Revenue Growth Rate in Tardive Dyskinesia Treatment Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva Pharmaceutical Industries Ltd
Neurocrine Biosciences, Inc
Sun Pharmaceutical Industries Ltd
SteriMax Inc.
Adamas Pharmaceuticals, Inc
Sanis
AbbVie Inc.
Frequently Asked Questions
Tardive Dyskinesia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tardive Dyskinesia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tardive Dyskinesia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports